The OptiOne™ Contrast Delivery Injector is designed for use in multiple imaging environments such as radiotherapy, trauma scanners, mammography and PET CT.
It is a fully featured single head injector compatible with both prefilled and consumable syringes, combining ease of use with multipurpose functionality.
Along with the OptiOne™ injector, Guerbet offers a complete range of consumables and services designed and certified1 to optimize the performance of the solution.
OptiVantage™ with its efficiency add-on, OptiBolus®
OptiVantage™ by Guerbet offers a solution in support of the American College of Radiology Committe recommendations
Optimal service and support designed to ensure the optimal performance of the injectors.
Learn moreContrast&Care® is a contrast product injection management solution that enables imaging centers to collect, archive, examine, and share injection data, including data on contrast products, adverse events, injector activity, information on estimated glomerular filtration rate, and other risk factors before a clinical exam.
Contrast&Care®Driven by its commitment to advance radiology, Guerbet Diagnostic Imaging has designed a comprehensive and complete portfolio of products and solutions for diagnostic imaging.
Diagnostic Imaging Solutions For RadiologyThe OptiOne™ Single-Head Contrast Media Injector is a class IIb (CE) medical device intended for use by qualified healthcare professionals; it is intended to inject radiopaque contrast media into a patient's vascular system to obtain diagnostic images when used in conjunction with computed tomography (CT) equipment. For complete information about precautions and optimal usage conditions, we recommend consulting the instructions for use supplied with the device or by your local Guerbet representative(s). For use only in countries with applicable health authority registrations.
Class IIb/CE
TÜV SÜD 0123
Manufacturer: Liebel-Flarsheim Company LLC
EC Rep: Guerbet
OptiOne™, OptiBolus®, OptiProtect™, LF™, Contrast&Care® are trademarks of Guerbet. Patents pending and issued patents. © Copyright 2018 Guerbet – All rights reserved. Document modification date: December 2022 P22001828.